Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonazoid CEUS for Renal Transplant Rejection
NCT02733029Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- May 2018
- Primary completion
- May 2022
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of sonazoid in renal transplant rejection (RTR), sponsored by Brigham and Women's Hospital. Started May 2018; status: completed.
02
Drugs
sonazoid
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT02733029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733029.